School of Medicine
Showing 1-10 of 28 Results
Biostatistician 1, Med/Quantitative Sciences Unit
Bio Rebecca is a biostatistician in the Quantitative Sciences Unit (QSU) with areas of study including developmental behavioral pediatrics (autism, ADHD, anxiety, and depression), school readiness in preschoolers, oncology, reproductive endocrinology & infertility, and natural language processing. She completed her MS in Statistics at Brigham Young University in 2016, where she collaborated with cardiologists to develop a new approach to diagnose rheumatic heart disease in pediatric patients in Samoa for her Master's thesis. Prior to joining the QSU, she provided statistical support in the Pediatric Critical Care division at the University of Utah. Rebecca moderates a local book club and writes poetry and short stories in her spare time.
Karleen Frances Giannitrapani
Instructor (Affiliated) [Vapahcs], Primary Care and Population Health
Bio Karleen Giannitrapani PhD MPH, is an Instructor in the Division of Primary Care and Population Health at Stanford University School of Medicine. As a Core Investigator at the Center for Innovation to Implementation (Ci2i) in the VA Palo Alto Health Care System she is the Principal Investigator of an effort to facilitate the role of employee occupational health during the Covid Pandemic. She is also a co-investigator and methods lead on multiple ongoing studies representing over 25 Million dollars of VA funding. Since 2018, she is the Associate Director of the VA Quality Improvement Resource Center (QuIRC) for Palliative care, one of three centers supporting Veterans Affairs Geriatrics and Extended Care nationally where she focuses on improving the processes that interdisciplinary teams can leverage to improve pain and symptom management among high-risk high-need patients. Her expertise includes organizational behavior, building teams, healthcare team functioning, implementation science, mixed methods-research, quality improvement, chronic pain, palliative care, and global health.
Associate Director, Quality Improvement Resource Center for Palliative Care (2018-Present)
Investigator, Center for Innovation to Implementation -Ci2i (2016-Present)
PhD, University of California Los Angeles, Health Policy and Management (2015)
MPH, University of California Los Angeles, Community Health Sciences (2010)
MA, University of California Los Angeles, African Studies (2010)
BA, Boston University, Anthropology and Religion (2006)
Christophe Gimmler, MD, MFT
Clinical Assistant Professor (Affiliated) [Vapahcs], Primary Care and Population Health
Bio Christophe Gimmler, MD, MFT, Assistant Clinical Professor of Medicine (Affiliated) at Stanford School of Medicine;
Staff Physician, Medical Service, VA Palo Alto Health Care System;
Licensed Marriage and Family Therapist.
After establishing and building the hospitalist and consult/liaison medicine service at the VA, Christophe now practices and teaches medical students and house staff in the primary care clinics there. He concurrently practices as a community psychotherapist and specializes in medical professionals. His central interest is the intersection of medicine and psychotherapy and, in particular, the application of psychological frameworks and skills to the practice of medicine, in addition to to resiliency and burnout prevention. He developed the Medical Student Resiliency Skills Training program (MedReST) for the Stanford School of Medicine as well as the Resiliency Curriculum Series for the internal medicine residency program. He received as undergraduate degree in biology and psychology and an MD from the University of Virginia, completed his internal medicine residency at Stanford, and received a Master’s in Counseling Psychology from Sofia University.
Foster Well-being Throughout the Career Trajectory: A Developmental Model of Physician Resilience Training:
Mayo Clinic Proceedings
Cordova MJ, Gimmler CE, Osterberg LG
2020; 95 (12):
Developing institutional infrastructure for physician wellness: qualitative Insights from VA physicians.
BMC Health Services Research
Schwartz, R., Shanafelt, T. D., Gimmler, C., Osterberg, L.
2020; 20 (1): 7
Adjunct Lecturer, Medicine - Med/Stanford Prevention Research Center
Bio Biosketch - Thomas J. Glynn, M.A., M.S., Ph.D. (psych.)
Dr. Glynn is, from 2014 to the present, Adjunct Lecturer, Stanford Prevention Research Center, Stanford University School of Medicine and Executive Team Member, Mayo Clinic Global Bridges Initiative. From 1998 to 2014, he was Director, Cancer Science and Trends and Director, International Cancer Control at the American Cancer Society (ACS). In these positions, he advised the ACS about emerging research and policy issues in cancer prevention and control, recommended cancer prevention and control research and policies, and participated in the development of an international cancer control program aimed at promoting cancer prevention-related research, advocacy, treatment, and policy change, particularly in middle- and low-income nations.
Prior to the ACS, Dr. Glynn was, from 1991 to 1994, Associate Director of the U.S. National Cancer Institute's (NCI) Cancer Control Science Program and, from 1991 to 1998, Chief of the NCI's Cancer Control Extramural Research Branch. There, he directed a national program of research aimed at reducing the incidence and prevalence of cancer, primarily through dietary change, tobacco use reduction, and adherence to cancer screening guidelines. From 1983 to 1991, he was Research Director for the NCI's Smoking, Tobacco, and Cancer Program and from 1978 to 1983, he was a Research Psychologist at the National Institute on Drug Abuse.
Dr. Glynn has published widely on cancer and tobacco use prevention and control, both in the scientific literature and for consumer, professional, and patient education and is co-developer of the 4A (now 5A) protocol for the treatment of tobacco dependence. In addition to his work at the ACS and NCI, he has served as a consultant on cancer control and tobacco issues to such groups as the National Academy of Sciences/Institute of Medicine, the National Research Council, the Robert Wood Johnson Foundation, the WHO, a variety of pharmaceutical organizations, and national, state and local governments.
He has also served as a Senior Scientific Reviewer for the U.S. Surgeon General's Reports on Tobacco and Health, as Director of the World Health Organization Study of Health, Economic, and Policy Implications of Tobacco Growth and Consumption in Developing Countries, and has been active in tobacco control programs in Eastern Europe, Central America, and India. He is a Fellow of the Society for Research on Nicotine and Tobacco and his awards include the U.S. National Institutes of Health Merit Award, the Polish Ministry of Health Service Award, the Guatemala National Council for Tobacco Prevention and Control Meritorious Service Award, the Society for Research on Nicotine and Tobacco John Slade Award, and the American Society of Preventive Oncology Joseph W. Cullen Memorial Award.